论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
Authors Zhang R, Yu Q, Lu W, Shen J, Zhou D, Wang Y, Gao S, Wang Z
Received 22 November 2018
Accepted for publication 7 March 2019
Published 24 May 2019 Volume 2019:12 Pages 4109—4118
DOI https://doi.org/10.2147/OTT.S195615
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Colin Mak
Peer reviewer comments 5
Editor who approved publication: Dr Takuya Aoki
Aim: Colorectal cancer (CRC) is a major malignancy in China, which is
the critical risk of people health. Many natural herbs extracts have been found
to exhibit good therapeutic effect on CRC. Our previous study found that grape
seed procyanidins B2 (PB2) would induce CRC cell death. However, the molecular
mechanism underlying its anti-tumor effect on CRC remains unclear. Thereby,
this study aimed to investigate the anti-tumor mechanism of PB2 on CRC.
Methods: CCK-8, western blotting, flow cytometry, qRT-PCR and animal study
were used in the current study.
Results: The in vitro and in vivo data demonstrated that PB2 could promote
the apoptosis of CRC cells in a dose-dependent manner, which was significantly
reversed by caspase 3 inhibitor. Meanwhile, PB2 dose-dependently induced
autophagy in CRC cells, which was markedly attenuated by autophagy inhibitor
3-MA. In addition, PB2 dose-dependently inhibited the expressions of p-PI3K,
p-Akt and p-mTOR in the cells.
Conclusion: PB2 dose-dependently induced apoptosis and autophagy in CRC cells
via downregulation of PI3K/Akt pathway. This study provided the experimental
basis for further development of PB2 as a new effective anticancer drug for the
patients with CRC.
Keywords: colorectal cancer, grape seed procyanidin extract, autophagy,
apoptosis, PI3K/Akt/mTOR signaling pathway
